Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-04-056827
Filing Date
2004-12-09
Accepted
2004-12-09 17:18:40
Documents
1
Period of Report
2004-12-07

Document Format Files

Seq Description Document Type Size
1 MAIN DOCUMENT DESCRIPTION b52723jm.html 4  
1 MAIN DOCUMENT DESCRIPTION b52723jm.xml 4 3824
  Complete submission text file 0001209191-04-056827.txt   5581
Mailing Address 300 THIRD STREET CAMBRIDGE MA 02142
Business Address 300 THIRD STREET CAMBRIDGE MA 02142 (617) 551-8200
ALNYLAM PHARMACEUTICALS, INC. (Issuer) CIK: 0001178670 (see all company filings)

EIN.: 770602661
SIC: 2834 Pharmaceutical Preparations

Mailing Address 75 SIDNEY ST CAMBRIDGE MA 02139
Business Address
MARAGANORE JOHN (Reporting) CIK: 0001180432 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-50743 | Film No.: 041194098